Lynn Vitale‐Cross

2.3k citations

22 papers · 1.5k indexed · h-index 16

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 10%
Immunology

Co-authors: J. Silvio Gutkind Alfredo Molinolo Daniel Martı́n Panomwat Amornphimoltham Yi Li Sandra Oršulić Harold Varmus Robert A. Soslow
Topics: PI3K/AKT/mTOR signaling in cancer (5 papers)Cancer-related Molecular Pathways (5 papers)Mesenchymal stem cell research (4 papers)
Cited by: Otorhinolaryngology Oncology Cancer Research
Journals: Science Nature Communications Journal of Clinical Oncology
Partner nations: United States Hungary Australia

In The Last Decade

Lynn Vitale‐Cross

22 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lynn Vitale‐Cross

Since Specialization

Citations

This map shows the geographic impact of Lynn Vitale‐Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Vitale‐Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Vitale‐Cross more than expected).

Fields of papers citing papers by Lynn Vitale‐Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Vitale‐Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Vitale‐Cross. The network helps show where Lynn Vitale‐Cross may publish in the future.

Co-authorship network of co-authors of Lynn Vitale‐Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Vitale‐Cross. A scholar is included among the top collaborators of Lynn Vitale‐Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Vitale‐Cross. Lynn Vitale‐Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bone marrow stromal cell-derived hepcidin has antimicrobial and immunomodulatory activities 2024 ·Scientific Reports ·(unknown),Balázs Mayer,Lynn Vitale‐Cross,Vamsee D. Myneni,(unknown),Krisztián Németh,Ildikó Szalayova,(unknown),(unknown),Aaron D. Gingerich,Huiling Han,Mark Westerman,Balázs Rada,Éva Mezey	4
2	The Potential Use of THP-1, a Monocytic Leukemia Cell Line, to Predict Immune-Suppressive Potency of Human Bone-Marrow Stromal Cells (BMSCs) In Vitro: A Pilot Study 2023 ·International Journal of Molecular Sciences ·Jiaqiang Ren,(unknown),Lynn Vitale‐Cross,David F. Stroncek,Pamela Gehron Robey,(unknown),Ildikó Szalayova,Balázs Mayer,Daniel Martı́n,Éva Mezey,Krisztián Németh	4
3	SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications 2022 ·EBioMedicine ·Lynn Vitale‐Cross,Ildikó Szalayova,(unknown),Miklós Palkovits,Éva Mezey	27
4	Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients 2020 ·Journal of Clinical Medicine ·(unknown),(unknown),Krisztián Németh,(unknown),(unknown),(unknown),Sandra D. MacDonald,Mehrnoosh Abshari,Joel Moss,Lynn Vitale‐Cross,(unknown),Éva Mezey	11
5	4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer 2019 ·Cancer Research ·Zhiyong Wang,Xiaodong Feng,Alfredo Molinolo,Daniel Martı́n,Lynn Vitale‐Cross,Nijiro Nohata,Mizuo Ando,Amy Wahba,Panomwat Amornphimoltham,Xingyu Wu,Mara Gilardi,Michael M. Allevato,Victoria H. Wu,Dana J. Steffen,Philip J. Tofilon,Nahum Sonenberg,Joseph A. Califano,Qianming Chen,Scott M. Lippman,J. Silvio Gutkind	54
6	Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 2019 ·Nature Communications ·Zhiyong Wang,Victoria H. Wu,Michael M. Allevato,Mara Gilardi,Yudou He,Juan Luis Callejas‐Valera,Lynn Vitale‐Cross,Daniel Martı́n,Panomwat Amornphimoltham,(unknown),Bryan S. Yung,Yusuke Goto,Alfredo Molinolo,Andrew B. Sharabi,Ezra E.W. Cohen,Qianming Chen,J. Guy Lyons,Ludmil B. Alexandrov,J. Silvio Gutkind	119
7	Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial 2018 ·Clinical Cancer Research ·Terry A. Day,Keisuke Shirai,Paul E. O’Brien,Maria Gisele Matheus,(unknown),Amit J. Sood,Anvesh Kompelli,(unknown),Daniel Martı́n,Lynn Vitale‐Cross,(unknown),Zhiyong Wang,Xingyu Wu,Olivier Harismendy,Alfredo Molinolo,Scott M. Lippman,Carter Van Waes,Éva Szabó,J. Silvio Gutkind	67
8	Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells 2018 ·Cytotherapy ·Vamsee D. Myneni,(unknown),Daniel Martı́n,Lynn Vitale‐Cross,(unknown),Joseph M. Firriolo,Brian I. Labow,Éva Mezey	9
9	Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia 2018 ·Cytotherapy ·(unknown),Lynn Vitale‐Cross,Balázs Mayer,(unknown),(unknown),Vamsee D. Myneni,Daniel Martı́n,(unknown),Krisztián Németh,Éva Mezey	15
10	Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo 2016 ·Hepatology ·Natalie Porat‐Shliom,Amber Jean Tietgens,Christina M. Van Itallie,Lynn Vitale‐Cross,Michal Jarník,(unknown),James M. Anderson,J. Silvio Gutkind,Roberto Weigert,Irwin M. Arias	39
11	Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3 2015 ·Cancer Prevention Research ·(unknown),Lynn Vitale‐Cross,Daniel Martı́n,Abraham Schneider,Alfredo Molinolo,Nitin Gangane,Thomas E. Carey,Jonathan B. McHugh,Christine M. Komarck,Heather M. Walline,William N. William,Raja R. Seethala,Robert L. Ferris,J. Silvio Gutkind	48
12	A pilot, single arm, prospective trial using neoadjuvant rapamycin prior to definitive therapy in head and neck squamous cell carcinoma. 2015 ·Journal of Clinical Oncology ·Keisuke Shirai,Terry A. Day,Éva Szabó,Carter Van Waes,Paul E. O’Brien,Maria Gisele Matheus,(unknown),Amit J. Sood,(unknown),Daniel Martı́n,Lynn Vitale‐Cross,Alfredo A. Molinolo,J. Silvio Gutkind	7
13	mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations 2014 ·JNCI Journal of the National Cancer Institute ·Zhiyong Wang,Daniel Martı́n,Alfredo Molinolo,Vyomesh Patel,Ramiro Iglesias‐Bartolomé,María Sol Degese,Lynn Vitale‐Cross,Qianming Chen,J. Silvio Gutkind	89
14	LKB1/AMPK and PKA Control ABCB11 Trafficking and Polarization in Hepatocytes 2014 ·PLoS ONE ·László Homolya,Dong Fu,Prabuddha Sengupta,Michal Jarník,Jean‐Pierre Gillet,Lynn Vitale‐Cross,J. Silvio Gutkind,Jennifer Lippincott‐Schwartz,Irwin M. Arias	37
15	Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions 2012 ·Cancer Prevention Research ·Lynn Vitale‐Cross,Alfredo Molinolo,Daniel Martı́n,Rania H. Younis,Takashi Maruyama,Vyomesh Patel,Wanjun Chen,Abraham Schneider,J. Silvio Gutkind	106
16	Parasympathetic Innervation Maintains Epithelial Progenitor Cells During Salivary Organogenesis 2010 ·Science ·Sarah M. Knox,Isabelle M.A. Lombaert,Xylena Reed,Lynn Vitale‐Cross,J. Silvio Gutkind,Matthew P. Hoffman	248
17	Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer 2009 ·Cancer Prevention Research ·Lynn Vitale‐Cross,Rakefet Czerninski,Panomwat Amornphimoltham,Vyomesh Patel,Alfredo Molinolo,J. Silvio Gutkind	74
18	Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter 2006 ·American Journal Of Pathology ·Ana R. Raimondi,Lynn Vitale‐Cross,Panomwat Amornphimoltham,J. Silvio Gutkind,Alfredo Molinolo	28
19	Induction of ovarian cancer by defined multiple genetic changes in a mouse model system 2002 ·Cancer Cell ·Sandra Oršulić,Yi Li,Robert A. Soslow,Lynn Vitale‐Cross,J. Silvio Gutkind,Harold Varmus	278
20	The pathway linking small GTP-binding proteins of the Rho family to cytoskeletal components and novel signaling kinase cascades 1996 ·Seminars in Cell and Developmental Biology ·J. Silvio Gutkind,Lynn Vitale‐Cross	15

About Lynn Vitale‐Cross

Lynn Vitale‐Cross is a scholar working on Genetics, Oncology and Otorhinolaryngology, having authored 22 papers that have together received 1.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (5 papers) and Mesenchymal stem cell research (4 papers). The work is most often cited by research in Otorhinolaryngology (108 citations), Oncology (537 citations) and Cancer Research (276 citations). Lynn Vitale‐Cross has collaborated with scholars based in United States, Hungary and Australia. Frequent co-authors include J. Silvio Gutkind, Alfredo Molinolo, Daniel Martı́n, Panomwat Amornphimoltham, Yi Li, Sandra Oršulić, Harold Varmus, Robert A. Soslow, Matthew P. Hoffman and Isabelle M.A. Lombaert. Their work appears in journals such as Science, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact